Company profile

Cosmo Artificial Intelligence - Ai, Ltd.

Cosmo Artificial Intelligence - Ai, Ltd. has 6 AI-enabled medical devices on the FDA list. The first decision was on April 9, 2021 and the most recent on May 29, 2026 (GI Genius™ Module 300 (GGM300-US);ColonPRO™ US (CPRO403S-US)). Its most common review panel is Gastroenterology-Urology (6 devices).

6AI devices
2021First decision
2026Latest decision
1Specialties

Per year

2021: 22023: 12024: 22026: 1
2021202320242026
Cosmo Artificial Intelligence - Ai, Ltd. AI devices per year: 2021 2, 2023 1, 2024 2, 2026 1

By specialty

  • Gastroenterology-Urology6

Timeline

  1. GI Genius™ Module 300 (GGM300-US);ColonPRO™ US (CPRO403S-US) · Gastroenterology-Urology · QNP
  2. GI Genius™ Module 100 (GGM100.US); GI Genius™ Module 200 (GGM200.US); ColonPRO™ 4.0 (CPRO40.US); GI Genius™ Module 300 (GGM300-US); ColonPRO™ 4.0 (CPRO40S-US) · Gastroenterology-Urology · QNP
  3. GI Genius™ Module 100 (GGM100.US); GI Genius™ Module 200 (GGM200.US); ColonPRO™ 4.0 (CPRO40.US) · Gastroenterology-Urology · QNP
  4. GI Genius System 100 and GI Genius System 200 · Gastroenterology-Urology · QNP
  5. GI Genius · Gastroenterology-Urology · QNP
  6. GI Genius · Gastroenterology-Urology · QNP